Compare LIDR & ALPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LIDR | ALPS |
|---|---|---|
| Founded | 2013 | 2017 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.5M | 66.6M |
| IPO Year | 2020 | 2024 |
| Metric | LIDR | ALPS |
|---|---|---|
| Price | $1.00 | $0.33 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.75 | N/A |
| AVG Volume (30 Days) | ★ 485.2K | 36.2K |
| Earning Date | 11-05-2026 | 07-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $233,000.00 | N/A |
| Revenue This Year | $952.79 | N/A |
| Revenue Next Year | $778.52 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.35 | N/A |
| 52 Week Low | $0.81 | $0.23 |
| 52 Week High | $3.05 | $1.72 |
| Indicator | LIDR | ALPS |
|---|---|---|
| Relative Strength Index (RSI) | 45.81 | 31.57 |
| Support Level | $0.81 | $0.23 |
| Resistance Level | $1.77 | $0.44 |
| Average True Range (ATR) | 0.07 | 0.02 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 58.23 | 5.26 |
AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.
ALPS Group Inc is an investment holding company involved in research and development, including stem cell and biotechnology-related business, and investing and managing businesses such as health and beauty centres and medical centres. The Company operates through Medical and Wellness, Life Science and Others segments. Medical and Wellness generates maximum revenue from non-surgical aesthetic services, surgical aesthetic services, medical consultation, health screenings, cellular therapy and research, and COVID-19 testing. Life Science provides whole-genome sequencing and pharmacogenomics, while Others comprises investment holding and provision of management services. The Company generates revenue in Malaysia.